
Sanjay Suri
About Sanjay Suri
Data last updated:
Sanjay Suri is a Whole-Time Director at Morepen Laboratories Limited (since 2019), Director at Morepen Rx Limited (since 2023) and Director at Happier Life Private Limited (since 2020), and holds 13 more current directorships. The companies operate in Pharma, FMCG and Financial Services. The 11 current companies with reported revenue have a combined latest revenue of ₹1,944 Cr; the largest is Morepen Laboratories Limited at ₹1,830 Cr (FY 2025). Earlier, Sanjay Suri was a Director at Joy Hotel And Resorts Private Limited (2008–2023) and Director at Blue Coast Infrastructure Development Private Limited (2001–2014) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 13 Aug 2019 | 1984 | ₹1,830 Cr (FY 2025) | Active | |
| Director | 17 Mar 2023 | 2023 | ₹113 Cr (FY 2025) | Active | |
| Director | 02 Aug 2020 | 2020 | ₹1.10 Cr (FY 2025) | Active | |
| Director | 16 Mar 2020 | 1994 | ₹45.7 Lakh (FY 2025) | Active | |
| Director | 10 Jul 2002 | 2000 | ₹11 Lakh (FY 2025) | Active | |
| Director | 30 Aug 2005 | 1998 | ₹4 Lakh (FY 2025) | Active | |
| Director | 31 Aug 2005 | 1994 | ₹2.2 Lakh (FY 2025) | Active | |
| Director | 01 Dec 2022 | 2000 | ₹55,000 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Feb 2008 | 1972 | ₹62,000 (FY 2023) | Active | |
| Director | 15 May 2001 | 1994 | Active | ||
| Director | 31 Aug 2005 | 1994 | ₹26,800 (FY 2025) | Active | |
| Managing Director | 21 Oct 2015 | 2010 | ₹26.3 Lakh (FY 2023) | Active | |
| Director | 06 Sep 2021 | 2021 | Active | ||
| Managing Director | 09 Mar 2003 | 2001 | ₹171 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Suri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Suri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Suri
Sanjay Suri currently holds 16 directorships: Morepen Laboratories Limited (Whole-Time Director, since 13 Aug 2019, revenue ₹1,830 Cr (FY 2025)); Morepen Rx Limited (Director, since 17 Mar 2023, revenue ₹113 Cr (FY 2025)); Happier Life Private Limited (Director, since 02 Aug 2020, revenue ₹1.10 Cr (FY 2025)); Liquid Holdings Private Limited (Director, since 16 Mar 2020, revenue ₹45.7 Lakh (FY 2025)); Total Care Limited (Director, since 10 Jul 2002, revenue ₹11 Lakh (FY 2025)); and 11 more.
Sanjay Suri was first appointed on 11 Jan 1994 as Director at Mid-Med Financial Services And Investments Private Limited. The most recent appointment on record is 02 Dec 2025 at Stellacore Llp.
The 11 current companies of Sanjay Suri that report revenue have a combined latest revenue of ₹1,944 Cr: Morepen Laboratories Limited ₹1,830 Cr (FY 2025); Morepen Rx Limited ₹113 Cr (FY 2025); Happier Life Private Limited ₹1.10 Cr (FY 2025); Liquid Holdings Private Limited ₹45.7 Lakh (FY 2025); Total Care Limited ₹11 Lakh (FY 2025); and 6 more.
Sanjay Suri held 6 earlier board appointments: Joy Hotel And Resorts Private Limited (Director, 06 Feb 2008 to 31 Dec 2023); Blue Coast Infrastructure Development Private Limited (Director, 15 May 2001 to 30 Oct 2014); Scope Credits And Financial Services Private Limited (Director, 31 Aug 2005 to 07 Nov 2014); Activa Generics Private Limited (Managing Director, 21 Oct 2015 to 09 Jul 2019); Morepen Devices Limited (Director, 06 Sep 2021 to 01 Oct 2021); and 1 more.
The current boards of Sanjay Suri's companies include Ajay Kumar Sharma (Morepen Laboratories Limited), Praveen Kumar Dutt (Morepen Laboratories Limited), Ranjit Khattar (Morepen Laboratories Limited), Savita (Morepen Laboratories Limited), Sharad Jain (Morepen Laboratories Limited), Sushil Suri (Morepen Laboratories Limited), among others.